A.R. Ketring

882 total citations
28 papers, 714 citations indexed

About

A.R. Ketring is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A.R. Ketring has authored 28 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A.R. Ketring's work include Radiopharmaceutical Chemistry and Applications (22 papers), Medical Imaging Techniques and Applications (9 papers) and Medical Imaging and Pathology Studies (6 papers). A.R. Ketring is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (22 papers), Medical Imaging Techniques and Applications (9 papers) and Medical Imaging and Pathology Studies (6 papers). A.R. Ketring collaborates with scholars based in United States and India. A.R. Ketring's co-authors include Wynn A. Volkert, Gary J. Ehrhardt, William Goeckeler, Richard A. Holmes, Silvia S. Jurisson, Mahdieh Abbasalizad Farhangi, Antony Williams, Kattesh V. Katti, Amitabh Singh and C. Higginbotham and has published in prestigious journals such as Inorganic Chemistry, International Journal of Radiation Oncology*Biology*Physics and Nuclear Medicine and Biology.

In The Last Decade

A.R. Ketring

28 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.R. Ketring United States 13 539 208 195 132 114 28 714
Alan R. Ketring United States 19 670 1.2× 212 1.0× 267 1.4× 145 1.1× 154 1.4× 38 933
C. Greg Pippin United States 14 573 1.1× 216 1.0× 149 0.8× 144 1.1× 160 1.4× 22 841
William Goeckeler United States 11 657 1.2× 341 1.6× 331 1.7× 69 0.5× 71 0.6× 20 913
Lara L. Chappell United States 16 625 1.2× 248 1.2× 189 1.0× 98 0.7× 173 1.5× 17 970
Ali Bahrami‐Samani Iran 15 502 0.9× 200 1.0× 188 1.0× 71 0.5× 95 0.8× 113 771
Karen Libson United States 18 753 1.4× 383 1.8× 293 1.5× 242 1.8× 140 1.2× 28 1.1k
C. Tsoukalas Greece 16 417 0.8× 187 0.9× 139 0.7× 77 0.6× 110 1.0× 42 630
G.E. Meinken United States 19 658 1.2× 144 0.7× 309 1.6× 116 0.9× 75 0.7× 57 923
Laura A. Bass United States 13 1.1k 2.0× 430 2.1× 344 1.8× 84 0.6× 181 1.6× 15 1.5k
Ming‐Kuan Chyan United States 17 623 1.2× 113 0.5× 156 0.8× 86 0.7× 59 0.5× 30 740

Countries citing papers authored by A.R. Ketring

Since Specialization
Citations

This map shows the geographic impact of A.R. Ketring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.R. Ketring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.R. Ketring more than expected).

Fields of papers citing papers by A.R. Ketring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.R. Ketring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.R. Ketring. The network helps show where A.R. Ketring may publish in the future.

Co-authorship network of co-authors of A.R. Ketring

This figure shows the co-authorship network connecting the top 25 collaborators of A.R. Ketring. A scholar is included among the top collaborators of A.R. Ketring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.R. Ketring. A.R. Ketring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jurisson, Silvia S., et al.. (2012). Separation methods for high specific activity radioarsenic. AIP conference proceedings. 215–217. 1 indexed citations
2.
Bryan, Jeffrey N., Dae Young Kim, Linda M. Berent, et al.. (2009). Comparison of Systemic Toxicities of 177Lu-DOTMP and 153Sm-EDTMP Administered Intravenously at Equivalent Skeletal Doses to Normal Dogs. Journal of Nuclear Medicine Technology. 37(1). 45–52. 23 indexed citations
3.
Ehrhardt, Gary J., A.R. Ketring, & C. Cutler. (2003). Radioisotope radiotherapy research and achievements at the University of Missouri Research Reactor. Czechoslovak Journal of Physics. 53(S1). A707–A712. 3 indexed citations
4.
Ma, Dangshe, C. Higginbotham, Timothy J. Hoffman, et al.. (2001). Development of an in vitro model for assessing the in vivo stability of lanthanide chelates. Nuclear Medicine and Biology. 28(2). 145–154. 60 indexed citations
6.
Berning, Douglas E., Kattesh V. Katti, Wynn A. Volkert, C. Higginbotham, & A.R. Ketring. (1998). 198Au-labeled hydroxymethyl phosphines as models for potential therapeutic pharmaceuticals. Nuclear Medicine and Biology. 25(6). 577–583. 24 indexed citations
7.
Higginbotham, C., Andrew J. Grall, Jean F. Vollano, et al.. (1997). Biodistribution of model 105Rh-labeled tetradentate thiamacrocycles in rats. Nuclear Medicine and Biology. 24(1). 85–92. 18 indexed citations
8.
Liang, Qi, Gary J. Ehrhardt, A.R. Ketring, & R.G. Miller. (1997). Effect of Stoichiometric and Preparation Parameters on W-188/Re-188 Gel Generator Performance. Radiochimica Acta. 79(2). 137–140. 11 indexed citations
9.
Goswami, Niranjan, Wynn A. Volkert, E. O. Schlemper, et al.. (1996). An Rh-105 complex of tetrathiacyclohexadecane diol with potential for formulating bifunctional chelates. Nuclear Medicine and Biology. 23(1). 33–40. 25 indexed citations
10.
Volkert, Wynn A., et al.. (1996). Comparisons of 105Rh(III) Chloride Complexation with [14]aneNS3, [14]aneN2S2 and [14]aneN4 Macrocycles in Aqueous Solution. Radiochimica Acta. 75(2). 83–96. 16 indexed citations
11.
Ma, Dangshe, A.R. Ketring, Gary J. Ehrhardt, & Wei‐Guo Jia. (1996). Production of radiolanthanides and radiotherapy research at MURR. Journal of Radioanalytical and Nuclear Chemistry. 206(1). 119–126. 17 indexed citations
13.
Li, Ning, et al.. (1996). In-vitro and in-vivo characterization of a Rh-105-tetrathiamacrocycle conjugate of a bombesin analogue. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 37. 1 indexed citations
14.
Jia, Wei‐Guo, et al.. (1996). 186Re/188Re labeled polypeptide microspheres as a potential radiation synovectomy agent. Journal of Radioanalytical and Nuclear Chemistry. 206(1). 107–117. 4 indexed citations
15.
Volkert, Wynn A., et al.. (1995). Transition metal chemistry of main group hydrazides, part 14: Evaluation of new Tc-99m chelates of thiol functionalized phosphorus hydrazides. Nuclear Medicine and Biology. 22(7). 849–857. 3 indexed citations
16.
Katti, Kattesh V., Pratik Singh, Kavita Katti, et al.. (1993). The Potential of Phosphinimines as Building Blocks for a New Generation of Radiopharmaceuticals. Phosphorus, sulfur, and silicon and the related elements. 75(1-4). 55–58. 2 indexed citations
17.
Troutner, D.E., et al.. (1992). Synthesis, characterization and biodistribution studies of a neutral-lipophilic Tc-99m N3S2 chelate. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 19(7). 791–795. 1 indexed citations
18.
Volkert, Wynn A., et al.. (1989). RADIOLABELED PHOSPHONIC ACID CHELATES: POTENTIAL THERAPEUTIC AGENTS FOR TREATMENT OF SKELETAL METASTASES. Drugs of the Future. 14(8). 799–799. 27 indexed citations
20.
Ketring, A.R., et al.. (1984). 186Re-HEDP: A Potential Therapeutic Bone Agent. Nuklearmedizin - NuclearMedicine. 23(2). 81–82. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026